Intelicanna Ltd (INTL) - Total Assets
Based on the latest financial reports, Intelicanna Ltd (INTL) holds total assets worth ILA63.16 Billion ILA (≈ $169.34 Million USD) as of September 2023. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check how aggressively does Intelicanna Ltd reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Intelicanna Ltd - Total Assets Trend (2012–2022)
This chart illustrates how Intelicanna Ltd's total assets have evolved over time, based on quarterly financial data. Explore Intelicanna Ltd strategic investment ratio to see how much of total assets are deployed in long-term investments.
Intelicanna Ltd - Asset Composition Analysis
Current Asset Composition (December 2022)
Intelicanna Ltd's total assets of ILA63.16 Billion consist of 3.3% current assets and 96.7% non-current assets.
| Asset Category | Amount (ILA) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ILA0.00 | 3.3% |
| Accounts Receivable | ILA0.00 | 0.0% |
| Inventory | ILA0.00 | 0.0% |
| Property, Plant & Equipment | ILA0.00 | 0.0% |
| Intangible Assets | ILA558.94 Million | 0.9% |
| Goodwill | ILA202.90 Million | 0.3% |
Asset Composition Trend (2012–2022)
This chart illustrates how Intelicanna Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see INTL market cap.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Intelicanna Ltd's current assets represent 3.3% of total assets in 2022, a decrease from 19.2% in 2012.
- Cash Position: Cash and equivalents constituted 3.3% of total assets in 2022, down from 19.2% in 2012.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 1.0% in 2012.
- Asset Diversification: The largest asset category is intangible assets at 0.9% of total assets.
Intelicanna Ltd Competitors by Total Assets
Key competitors of Intelicanna Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Tonghua Dongbao Pharmaceutical Co Ltd
SHG:600867
|
China | CN¥8.25 Billion |
|
Eris Lifesciences Limited
NSE:ERIS
|
India | Rs71.60 Billion |
|
Zhejiang Hisun Pharmaceutical Co Ltd
SHG:600267
|
China | CN¥13.81 Billion |
|
Lotus Pharmaceutical Co Ltd
TW:1795
|
Taiwan | NT$106.15 Billion |
|
Tasly Pharmaceutical Group Co Ltd
SHG:600535
|
China | CN¥15.69 Billion |
|
Changzhou Qianhong Biopharma Co Ltd
SHE:002550
|
China | CN¥3.23 Billion |
|
Renhe Pharmacy Co Ltd
SHE:000650
|
China | CN¥7.93 Billion |
|
Sun Pharma Advanced Research Company Limited
NSE:SPARC
|
India | Rs3.22 Billion |
Intelicanna Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 22.02 | 16.67 | 31.51 |
| Quick Ratio | 22.02 | 16.67 | 31.51 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | ILA8.33 Billion | ILA4.30 Billion | ILA5.93 Billion |
Intelicanna Ltd - Advanced Valuation Insights
This section examines the relationship between Intelicanna Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | - |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 1.4% |
| Total Assets | ILA62.21 Billion |
| Market Capitalization | $7.78 Million USD |
Valuation Analysis
Below Book Valuation: The market values Intelicanna Ltd's assets below their book value (0.00x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Intelicanna Ltd's assets grew by 1.4% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Intelicanna Ltd (2012–2022)
The table below shows the annual total assets of Intelicanna Ltd from 2012 to 2022.
| Year | Total Assets | Change |
|---|---|---|
| 2022-12-31 | ILA62.21 Billion ≈ $166.78 Million |
+1.36% |
| 2021-12-31 | ILA61.37 Billion ≈ $164.54 Million |
-6.57% |
| 2020-12-31 | ILA65.69 Billion ≈ $176.11 Million |
+15.86% |
| 2019-12-31 | ILA56.70 Billion ≈ $152.01 Million |
+7.92% |
| 2018-12-31 | ILA52.54 Billion ≈ $140.85 Million |
-0.18% |
| 2017-12-31 | ILA52.63 Billion ≈ $141.10 Million |
+12.94% |
| 2016-12-31 | ILA46.60 Billion ≈ $124.93 Million |
+2.08% |
| 2015-12-31 | ILA45.65 Billion ≈ $122.38 Million |
+1.16% |
| 2014-12-31 | ILA45.13 Billion ≈ $120.98 Million |
+10.58% |
| 2013-12-31 | ILA40.81 Billion ≈ $109.40 Million |
+0.14% |
| 2012-12-31 | ILA40.75 Billion ≈ $109.25 Million |
-- |
About Intelicanna Ltd
Intelicanna Ltd operates as pharmaceutical company in Israel. It grows, cultivates, produces, research, markets, and sells medical cannabis. The company was formerly known as Tefen Industrial Engineering & Management & Systems Analysis and changed its name to Intelicanna Ltd in March 2019. The company was founded in 1981 and is headquartered in Hod Hasharon, Israel.